# Fecal Microbiota Transplantation (FMT)

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/fecal-microbiota-transplantation-fmt
Canonical HTML page: https://getbiobrief.com/entity/fecal-microbiota-transplantation-fmt

## Recent coverage (1 stories)

### 2 Probiotic Strains Backed by RCTs, Yet Gut Microbiome Market Outpaces Science
2026-07-28 23:48:58 · Sentiment: Neutral · Impact: 5/10 · Sources: 5

The gut microbiome is a rapidly growing focus for biopharma, yet clinical validation remains sparse: only two probiotic strains—Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG—have strong RCT evidence. Without a consensus definition of a healthy microbiome, therapeutic developers face significant regulatory and scientific challenges.
Full story: https://getbiobrief.com/story/2-probiotic-strains-backed-by-rcts-but-gut-microbiome-market-outpaces-science

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.